77 results
8-K
EX-99.1
BAX
Baxter International Inc.
6 Jul 23
Regulation FD Disclosure
8:30am
and Linet antitrust litigation or other claims; the impact of competitive products and pricing, including generic competition, drug reimportation
8-K
EX-3.1
m1ybme3
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
4wzra wcpu8
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-2.1
0blz1h dilt
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
ksyl0g
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
EX-3.2
x243yxs viz7
6 May 22
Material Modifications to Rights of Security Holders
4:57pm
8-K
EX-99.2
bun53
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
EX-2.1
dqatxbsis3ee 18
2 Sep 21
Entry into a Material Definitive Agreement
7:10am
8-K
31bt9ll 36ub8fnt573
2 Sep 21
Entry into a Material Definitive Agreement
7:10am